✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Insmed Inc

Common Name
Insmed
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
1,271
Ticker
INSM
Exchange
NASDAQ/NGS
Website
insmed.com
Description
Insmed Inc. is a biopharmaceutical company dedicated to enhancing the lives of patients with rare diseases. The company's primary focus is on the development and commercialization of treatments for se...

Insmed's Financial Statements Preview

Below are the financial statements of Insmed, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Product revenues, net
363.71a
305.21a
245.36a
Operating expenses
Cost of product revenues (excluding amortization of intangible assets)
-85.74a
-65.57a
-55.13a
Research and development
-598.37a
-571.01a
-397.52a
Selling, general and administrative
-461.12a
-344.5a
-265.78a
Amortization of intangible assets
-5.05a
-5.05a
-5.05a
Change in fair value of deferred and contingent consideration liabilities
-91.68a
-28.7a
-20.8a
Total operating expenses
-1,241.96a
-1,014.83a
-702.68a
Operating loss
-878.25a
-709.63a
-457.32a
Investment income
53.31a
42.13a
11.08a
Interest expense
-84.91a
-81.69a
-26.45a
Change in fair value of interest rate swap
-0.24a
0.32a
-1.53a
Other income (expense), net
0.03a
1.86a
-5.94a
Loss before income taxes
-910.07a
-747.01a
-480.15a
Provision for income taxes
-3.71a
-2.56a
-1.38a
Net loss
-913.77a
-749.57a
-481.53a
Limited Data Preview
You are viewing a limited preview of Insmed’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Insmed’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Insmed’s data sources below and access millions more through our Disclosure Search.

a. Insmed's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?